These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 16622123)
1. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). Andrieu N; Goldgar DE; Easton DF; Rookus M; Brohet R; Antoniou AC; Peock S; Evans G; Eccles D; Douglas F; Noguès C; Gauthier-Villars M; Chompret A; Van Leeuwen FE; Kluijt I; Benitez J; Arver B; Olah E; Chang-Claude J; ; ; ; J Natl Cancer Inst; 2006 Apr; 98(8):535-44. PubMed ID: 16622123 [TBL] [Abstract][Full Text] [Related]
2. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445 [TBL] [Abstract][Full Text] [Related]
3. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Lecarpentier J; Noguès C; Mouret-Fourme E; Gauthier-Villars M; Lasset C; Fricker JP; Caron O; Stoppa-Lyonnet D; Berthet P; Faivre L; Bonadona V; Buecher B; Coupier I; Gladieff L; Gesta P; Eisinger F; Frénay M; Luporsi E; Lortholary A; Colas C; Dugast C; Longy M; Pujol P; Tinat J; ; Lidereau R; Andrieu N Breast Cancer Res; 2012 Jul; 14(4):R99. PubMed ID: 22762150 [TBL] [Abstract][Full Text] [Related]
4. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414 [TBL] [Abstract][Full Text] [Related]
5. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971 [TBL] [Abstract][Full Text] [Related]
6. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Antoniou AC; Shenton A; Maher ER; Watson E; Woodward E; Lalloo F; Easton DF; Evans DG Breast Cancer Res; 2006; 8(6):R72. PubMed ID: 17187672 [TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. Brohet RM; Goldgar DE; Easton DF; Antoniou AC; Andrieu N; Chang-Claude J; Peock S; Eeles RA; Cook M; Chu C; Noguès C; Lasset C; Berthet P; Meijers-Heijboer H; Gerdes AM; Olsson H; Caldes T; van Leeuwen FE; Rookus MA J Clin Oncol; 2007 Sep; 25(25):3831-6. PubMed ID: 17635951 [TBL] [Abstract][Full Text] [Related]
8. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J; Lubinski J; Lynch HT; Klijn J; Ghadirian P; Neuhausen SL; Kim-Sing C; Foulkes WD; Moller P; Isaacs C; Domchek S; Randall S; Offit K; Tung N; Ainsworth P; Gershoni-Baruch R; Eisen A; Daly M; Karlan B; Saal HM; Couch F; Pasini B; Wagner T; Friedman E; Rennert G; Eng C; Weitzel J; Sun P; Narod SA; ; Garber J; Osborne M; Fishman D; McLennan J; McKinnon W; Merajver S; Olsson H; Provencher D; Pasche B; Evans G; Meschino WS; Lemire E; Chudley A; Rayson D; Bellati C Breast Cancer Res Treat; 2007 Oct; 105(2):221-8. PubMed ID: 17245541 [TBL] [Abstract][Full Text] [Related]
9. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. Andrieu N; Easton DF; Chang-Claude J; Rookus MA; Brohet R; Cardis E; Antoniou AC; Wagner T; Simard J; Evans G; Peock S; Fricker JP; Nogues C; Van't Veer L; Van Leeuwen FE; Goldgar DE J Clin Oncol; 2006 Jul; 24(21):3361-6. PubMed ID: 16801631 [TBL] [Abstract][Full Text] [Related]
10. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759 [TBL] [Abstract][Full Text] [Related]
11. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866 [TBL] [Abstract][Full Text] [Related]
12. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
13. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for Li H; Terry MB; Antoniou AC; Phillips KA; Kast K; Mooij TM; Engel C; Noguès C; Stoppa-Lyonnet D; Lasset C; Berthet P; Mari V; Caron O; ; Barrowdale D; Frost D; Brewer C; Evans DG; Izatt L; Side L; Walker L; Tischkowitz M; Rogers MT; Porteous ME; Snape K; ; Meijers-Heijboer HEJ; Gille JJP; Blok MJ; Hoogerbrugge N; ; Daly MB; Andrulis IL; Buys SS; John EM; McLachlan SA; Friedlander M; ; Tan YY; Osorio A; Caldes T; Jakubowska A; Simard J; Singer CF; Olah E; Navratilova M; Foretova L; Gerdes AM; Roos-Blom MJ; Arver B; Olsson H; Schmutzler RK; Hopper JL; Milne RL; Easton DF; Van Leeuwen FE; Rookus MA; Andrieu N; Goldgar DE Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):368-378. PubMed ID: 31792088 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Haile RW; Thomas DC; McGuire V; Felberg A; John EM; Milne RL; Hopper JL; Jenkins MA; Levine AJ; Daly MM; Buys SS; Senie RT; Andrulis IL; Knight JA; Godwin AK; Southey M; McCredie MR; Giles GG; Andrews L; Tucker K; Miron A; Apicella C; Tesoriero A; Bane A; Pike MC; ; ; Whittemore AS Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1863-70. PubMed ID: 17021353 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055 [TBL] [Abstract][Full Text] [Related]
17. Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers. Park JS; Lee ST; Han JW; Kim TI; Nam EJ; Park HS Clin Breast Cancer; 2018 Oct; 18(5):362-373.e1. PubMed ID: 29673794 [TBL] [Abstract][Full Text] [Related]
18. Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies. Pan H; He Z; Ling L; Ding Q; Chen L; Zha X; Zhou W; Liu X; Wang S Cancer Epidemiol; 2014 Feb; 38(1):1-8. PubMed ID: 24332935 [TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women. Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189 [TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Narod SA; Dubé MP; Klijn J; Lubinski J; Lynch HT; Ghadirian P; Provencher D; Heimdal K; Moller P; Robson M; Offit K; Isaacs C; Weber B; Friedman E; Gershoni-Baruch R; Rennert G; Pasini B; Wagner T; Daly M; Garber JE; Neuhausen SL; Ainsworth P; Olsson H; Evans G; Osborne M; Couch F; Foulkes WD; Warner E; Kim-Sing C; Olopade O; Tung N; Saal HM; Weitzel J; Merajver S; Gauthier-Villars M; Jernstrom H; Sun P; Brunet JS J Natl Cancer Inst; 2002 Dec; 94(23):1773-9. PubMed ID: 12464649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]